Results 1 to 10 of about 934,412 (371)

Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge

International Journal of Stroke, 2020
Background Atrial fibrillation is the most frequent cardiac arrhythmia. It has been estimated that 6–12 million people worldwide will suffer this condition in the US by 2050 and 17.9 million people in Europe by 2060.
G. Lippi, F. Sanchis-Gomar, G. Cervellin
semanticscholar   +1 more source

Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review)

Cardiovascular Electrophysiology, 2022
The last three decades have been characterized by an exponential increase in knowledge and advances in the clinical management of atrial fibrillation.
K. Bizhanov, Kuat Аbzaliyev, A. Baimbetov, A. Sarsenbayeva, Evgeny Lyan   +4 more
semanticscholar   +1 more source

Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study

British medical journal
Objectives To examine how the lifetime risks of atrial fibrillation and of complications after atrial fibrillation changed over time. Design Danish, nationwide, population based cohort study.
Nicklas Vinter, P. Cordsen, S. Johnsen, Laila Staerk, Emelia J. Benjamin, Lars Frost, Ludovic Trinquart   +6 more
semanticscholar   +1 more source

Autoimmune Atrial Fibrillation or Atrial Fibrillation–Induced Autoimmunity? A New Atrial Fibrillation Begets Atrial Fibrillation Pathway?

Circulation, 2023
499 The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. Correspondence to: Vincent Algalarrondo, MD, PhD, Service de Cardiologie, Unité de Rythmologie, Hôpital Bichat Claude Bernard, 46 Bd
V. Algalarrondo, F. Extramiana
semanticscholar   +1 more source

Postoperative Atrial Fibrillation Begets Atrial Fibrillation.

JACC: Clinical Electrophysiology
Jeffrey Yim, Andrew D. Krahn
semanticscholar   +3 more sources

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

The Lancet, 2014
Christian T. Ruff, R. Giugliano, E. Braunwald, Elaine B. Hoffman, Naveen Deenadayalu, M. Ezekowitz, A. Camm, Jeffrey I. Weitz, Basil S. Lewis, A. Parkhomenko, T. Yamashita, E. Antman   +11 more
semanticscholar   +1 more source

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Chest, 2010
G. Lip, R. Nieuwlaat, R. Pisters, D. Lane, H. Crijns   +4 more
semanticscholar   +1 more source

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Journal of the American Medical Association (JAMA), 2001
A. Go, E. Hylek, Katherine Phillips, Yuchiao Chang, Lori Henault, Joeseph V. Selby, Daniel E. Singer   +6 more
semanticscholar   +1 more source

Apixaban versus Warfarin in Patients with Atrial Fibrillation

, 2012
Shinya Goto
semanticscholar   +1 more source

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Annals of Internal Medicine, 2007
R. Hart, L. Pearce, M. Aguilar
semanticscholar   +1 more source